Abstract

RDS-1 is designed to bring together the scientific community - researchers, physicians, psychoanalysts, technologists, academicians, mental health care professionals, drug-experts, policy makers, etc to discuss the present and future perspectives related to and from all areas, but not limited to clinical aspects like neurobiology, screening steps with standardized tools, prevention strategies, development of innovative treatment methods, pharmaco-therapies and other management options like nutrigenomics, epigenetics, neuroimaging tools for therapy and recovery, ethical policies and social issues related to all areas of addictive behaviors aspects, twelve-step fellowships, etc